Redmile Group LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Redmile Group LLC | 2,165,586 4.600% | -546,030 (-20.14%) | Filing |
| 2021-02-16 4:07 pm Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Redmile Group LLC | 2,711,616 6.900% | 2,711,616 (New Position) | Filing |